The Artificial Pancreas is Finally Coming to Market

According to a story in Tuesday’s USA Today, the first artificial pancreas systems are beginning to come to market.

The artificial pancreas is a nickname given to wearable devices that take on the dual task of monitoring glucose levels as well as administering insulin. Also referred to as a “closed-loop” system because  the devices do their work with no help from humans.

The first system to hit the market is the MiniMed 670G from Medtronic. Other companies have active studies underway and hope to bring their products to the marketplace later this year or in 2018. Those companies include startup Bigfoot Biomedical, Insulet, and a partnership between Dexcom, Tandem, and TypeZero.

The article states that these systems actually aren’t an option for most diabetes, many of whom have type 2 diabetes. The artificial pancreas is for the 10% of diabetes patients who have type 1 diabetes.

Read the entire article at USA Today.

You may also like

  • Can Intensive Medical Treatment Reverse Type 2 Diabetes?

    Type 2 diabetes can be reversed with intensive medical treatment using oral medications, insulin and lifestyle therapies, according to a study published in The Journal of Clinical Endocrinology & Metabolism. Researchers led by Hertzel C. Gerstein, MD, MSc, FRCPC, of McMaster University and Hamilton Health Sciences in Hamilton, Ontario, Canada randomly divided 83 individuals with…

  • Recent Survey Finds Many Adults with Diabetes Unaware of Their Increased Risk for Certain Serious Illnesses

    Many adults with diabetes are unaware of their increased risk for certain serious illnesses, according to a recent national, online consumer awareness survey sponsored by Merck and the American Diabetes Association, and conducted by Harris Poll. In the survey of 1,003 U.S. adults ages 18 years and older diagnosed with diabetes, respondents were twice as…